Marzia Varettoni
Marzia Varettoni
Dirigente Medico, Dipartimento di Ematologia e Oncologia, Fondazione IRCCS Policlinico San Matteo
Email verificata su
Citata da
Citata da
Incidence, presenting features and outcome of extramedullary disease in multiple myeloma: a longitudinal study on 1003 consecutive patients
M Varettoni, A Corso, G Pica, S Mangiacavalli, C Pascutto, M Lazzarino
Annals of Oncology 21 (2), 325-330, 2010
MYD88 L265P in Waldenström macroglobulinemia, immunoglobulin M monoclonal gammopathy, and other B-cell lymphoproliferative disorders using conventional and quantitative allele …
L Xu, ZR Hunter, G Yang, Y Zhou, Y Cao, X Liu, E Morra, A Trojani, ...
Blood, The Journal of the American Society of Hematology 121 (11), 2051-2058, 2013
Prevalence and clinical significance of the MYD88 (L265P) somatic mutation in Waldenström’s macroglobulinemia and related lymphoid neoplasms
M Varettoni, L Arcaini, S Zibellini, E Boveri, S Rattotti, R Riboni, A Corso, ...
Blood, The Journal of the American Society of Hematology 121 (13), 2522-2528, 2013
Targeting mutant BRAF in relapsed or refractory hairy-cell leukemia
E Tiacci, JH Park, L De Carolis, SS Chung, A Broccoli, S Scott, F Zaja, ...
New England Journal of Medicine 373 (18), 1733-1747, 2015
Prognostic factors for thrombosis, myelofibrosis, and leukemia in essential thrombocythemia: a study of 605 patients
F Passamonti, E Rumi, L Arcaini, E Boveri, C Elena, D Pietra, S Boggi, ...
haematologica 93 (11), 1645-1651, 2008
COVID-19 severity and mortality in patients with chronic lymphocytic leukemia: a joint study by ERIC, the European Research Initiative on CLL, and CLL Campus
L Scarfò, T Chatzikonstantinou, GM Rigolin, G Quaresmini, M Motta, ...
Leukemia 34 (9), 2354-2363, 2020
The BRAF V600E mutation in hairy cell leukemia and other mature B-cell neoplasms
L Arcaini, S Zibellini, E Boveri, R Riboni, S Rattotti, M Varettoni, ...
Blood, The Journal of the American Society of Hematology 119 (1), 188-191, 2012
Antiviral treatment in patients with indolent B-cell lymphomas associated with HCV infection: a study of the Fondazione Italiana Linfomi
L Arcaini, D Vallisa, S Rattotti, VV Ferretti, AJM Ferreri, P Bernuzzi, ...
Annals of Oncology 25 (7), 1404-1410, 2014
Adverse events occurring during bone marrow or peripheral blood progenitor cell infusion: analysis of 126 cases
EP Alessandrino, P Bernasconi, D Caldera, A Colombo, M Bonfichi, ...
Bone Marrow Transplantation 23 (6), 533-537, 1999
Clonal architecture of CXCR4 WHIM‐like mutations in Waldenström Macroglobulinaemia
L Xu, ZR Hunter, N Tsakmaklis, Y Cao, G Yang, J Chen, X Liu, S Kanan, ...
British journal of haematology 172 (5), 735-744, 2016
A different schedule of zoledronic acid can reduce the risk of the osteonecrosis of the jaw in patients with multiple myeloma
A Corso, M Varettoni, P Zappasodi, C Klersy, S Mangiacavalli, G Pica, ...
Leukemia 21 (7), 1545-1548, 2007
Consensus treatment recommendations from the tenth International Workshop for Waldenström Macroglobulinaemia
JJ Castillo, RH Advani, AR Branagan, C Buske, MA Dimopoulos, S D'Sa, ...
The Lancet Haematology 7 (11), e827-e837, 2020
Fludarabine plus cyclophosphamide and rituximab in Waldenstrom macroglobulinemia: an effective but myelosuppressive regimen to be offered to patients with advanced disease
A Tedeschi, G Benevolo, M Varettoni, ML Battista, PL Zinzani, C Visco, ...
Cancer 118 (2), 434-443, 2012
Central nervous system involvement by Waldenström macroglobulinaemia (Bing‐Neel syndrome): a multi‐institutional retrospective study
JJ Castillo, S D'Sa, MP Lunn, MC Minnema, A Tedeschi, F Lansigan, ...
British Journal of Haematology 172 (5), 709-715, 2016
Stereotyped patterns of B-cell receptor in splenic marginal zone lymphoma
S Zibellini, D Capello, F Forconi, P Marcatili, D Rossi, S Rattotti, ...
haematologica 95 (10), 1792, 2010
Pattern of somatic mutations in patients with Waldenström macroglobulinemia or IgM monoclonal gammopathy of undetermined significance
M Varettoni, S Zibellini, I Defrancesco, VV Ferretti, E Rizzo, L Malcovati, ...
Haematologica 102 (12), 2077, 2017
Immune-mediated neuropathies in myeloma patients treated with bortezomib
S Ravaglia, A Corso, G Piccolo, A Lozza, E Alfonsi, S Mangiacavalli, ...
Clinical neurophysiology 119 (11), 2507-2512, 2008
Bortezomib-induced peripheral neuropathy in multiple myeloma: a comparison between previously treated and untreated patients
A Corso, S Mangiacavalli, M Varettoni, C Pascutto, P Zappasodi, ...
Leukemia research 34 (4), 471-474, 2010
Ibrutinib for the treatment of Bing-Neel syndrome: a multicenter study
JJ Castillo, G Itchaki, J Paludo, M Varettoni, C Buske, TA Eyre, JC Chavez, ...
Blood, The Journal of the American Society of Hematology 133 (4), 299-305, 2019
Zoledronic acid down‐regulates adhesion molecules of bone marrow stromal cells in multiple myeloma: a possible mechanism for its antitumor effect
A Corso, E Ferretti, M Lunghi, P Zappasodi, S Mangiacavalli, M De Amici, ...
Cancer 104 (1), 118-125, 2005
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20